1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Athlete%s Foot (Tinea Pedis)-Pipeline Insights, 2017


DelveInsight’s, “ Athlete's Foot (Tinea Pedis)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Athlete's Foot (Tinea Pedis). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Athlete's Foot (Tinea Pedis). DelveInsight’s Report also assesses the Athlete's Foot (Tinea Pedis) therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Athlete's Foot (Tinea Pedis)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Athlete's Foot (Tinea Pedis) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Athlete's Foot (Tinea Pedis) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Athlete%s Foot (Tinea Pedis)-Pipeline Insights, 2017
Illustrative

- Athlete's Foot (Tinea Pedis) Overview
- Athlete's Foot (Tinea Pedis) Pipeline Therapeutics
- Athlete's Foot (Tinea Pedis) Therapeutics under Development by Companies
- Athlete's Foot (Tinea Pedis) Filed and Phase III Products
- Comparative Analysis
- Athlete's Foot (Tinea Pedis) Phase II Products
- Comparative Analysis
- Athlete's Foot (Tinea Pedis) Phase I and IND Filed Products
- Comparative Analysis
- Athlete's Foot (Tinea Pedis) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Athlete's Foot (Tinea Pedis) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Athlete's Foot (Tinea Pedis) - Discontinued Products
- Athlete's Foot (Tinea Pedis) - Dormant Products
- Companies Involved in Therapeutics Development for Athlete's Foot (Tinea Pedis)
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Athlete's Foot (Tinea Pedis), 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Athlete's Foot (Tinea Pedis) Assessment by Monotherapy Products
- Athlete's Foot (Tinea Pedis) Assessment by Combination Products
- Athlete's Foot (Tinea Pedis) Assessment by Route of Administration
- Athlete's Foot (Tinea Pedis) Assessment by Stage and Route of Administration
- Athlete's Foot (Tinea Pedis) Assessment by Molecule Type
- Athlete's Foot (Tinea Pedis) Assessment by Stage and Molecule Type
- Athlete's Foot (Tinea Pedis) Therapeutics - Discontinued Products
- Athlete's Foot (Tinea Pedis) Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Athlete's Foot (Tinea Pedis), 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Athlete's Foot (Tinea Pedis) Assessment by Monotherapy Products
- Athlete's Foot (Tinea Pedis) Assessment by Combination Products
- Athlete's Foot (Tinea Pedis) Assessment by Route of Administration
- Athlete's Foot (Tinea Pedis) Assessment by Stage and Route of Administration
- Athlete's Foot (Tinea Pedis) Assessment by Molecule Type
- Athlete's Foot (Tinea Pedis) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dermatophytic Onychomycosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014 - 2025

Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global antifungal drugs market was valued at USD 10.7 billion in 2015 and is expected to reach a value of USD 12.6 billion by 2025. The increasing incidence of fungal infections worldwide is the key ...

Global Antifungal Drugs Market Analysis & Trends - Industry Forecast to 2025

Global Antifungal Drugs Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • January 2017
  • by Accuray Research LLP

The Global Antifungal Drugs Market is poised to grow at a CAGR of around 1.8% over the next decade to reach approximately $12.8 billion by 2025. Some of the prominent trends that the market is witnessing ...


Download Unlimited Documents from Trusted Public Sources

The future of the Pain Relief Industry in the UK

  • February 2017
    5 pages
  • Pain Relief  

  • United Kingdom  

View report >

Antiseptics Markets

  • December 2016
    58 pages
  • Antiseptics  

    Anti-Infective  

View report >

Spinach Industry in the US

  • December 2016
    9 pages
  • Spinach  

    Food  

    Mineral Supplem...  

  • United States  

View report >

Otc Industry In India

9 months ago

Related Market Segments :

Antifungal

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.